Results 15,681-15,700 of 24,567 for speaker:Róisín Shortall

Health Service Budget: Motion [Private Members] (10 Jul 2012)

Róisín Shortall: I move amendment No. 1: To delete all words after "Dáil Éireann" and substitute the following: "— noting that the Health Service Executive (HSE) is facing a significant challenge in 2012 given the need to set expenditure levels within the parameters of the National Recovery Plan; — acknowledging the significant reductions which the health sector has experienced over the last three...

Written Answers — Medical Cards: Medical Cards (5 Jul 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — General Practitioner Services: General Practitioner Services (5 Jul 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Medicinal Products: Medicinal Products (5 Jul 2012)

Róisín Shortall: Roaccutane (active substance, isotretinoin) is authorised for treating severe forms of acne which have been resistant to other standard therapies. It should only be prescribed by or under the supervision of doctors with expertise in using the product and with a full understanding of the risks of therapy and the monitoring requirements. Under European and Irish legislation, all medicinal...

Written Answers — Long-Term Illness Scheme: Long-Term Illness Scheme (5 Jul 2012)

Róisín Shortall: The Programme for Government commits to reforming the current public health system by introducing Universal Health Insurance with equal access to care for all. As part of this, the Government is committed to introducing, on a phased basis, GP care without fees within its first term of office. Primary legislation is required to give effect to Government commitment to introduce a universal GP...

Written Answers — Medical Cards: Medical Cards (5 Jul 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Hospital Services (5 Jul 2012)

Róisín Shortall: I thank Deputy McHugh for raising this matter. I am responding on behalf of the Minister for Health, Deputy Reilly. The Deputy has raised the important issue of how we organise our health services to ensure we have safe and consistent treatment for patients throughout the country in a way that is affordable. This is being tackled through the clinical programmes and through the...

Hospital Services (5 Jul 2012)

Róisín Shortall: The Deputy is absolutely correct that there is significant potential for a high level of co-operation between our health service and its equivalent in the North. Many of the possibilities are being explored actively. There is much potential for synergy. Just last weekend, I met two of my counterparts, Mr. McCann and Mr. Bell, on co-operation in respect of drugs and alcohol. We will be...

Ambulance Service (5 Jul 2012)

Róisín Shortall: I thank the Deputies for giving me the opportunity to address this issue. I am responding on behalf of the Minister for Health, Deputy Reilly. The HSE's national ambulance service, NAS, has been progressively improving and modernising emergency ambulance services in Cork and Kerry. As part of this process, stations and crews are changing from being on call to having on-duty rostering....

Ambulance Service (5 Jul 2012)

Róisín Shortall: I very much appreciate the concerns raised by the Deputies. As I stated in my reply, the HSE ambulance service is committed to better management of absenteeism. Quite clearly, there was an issue recently and that level of service is a matter of concern. I am willing to undertake to convey the concerns expressed by both Deputies to the Minister for Health.

Written Answers — Medicinal Products: Medicinal Products (4 Jul 2012)

Róisín Shortall: Ivacaftor (Kalydeco) received a positive opinion from the Committee for Medicinal Products for Human Use at EU level in May 2012. Marketing authorisation issued by the EU Commission is anticipated in due course. Should the manufacturers make an application for inclusion of the product on the GMS and community drugs schemes, that application shall be considered in accordance with the relevant...

Written Answers — Dental Services: Dental Services (4 Jul 2012)

Róisín Shortall: The HSE is collating a breakdown of the number of dentists employed and I will forward this information to the Deputy as soon as it is available. The HSE has no central policy to recruit additional dentists. However, the current Employment Control Framework for the health sector gives the HSE some flexibility in relation to filling posts in order to protect front line services in so far as...

Written Answers — Primary Care Services: Primary Care Services (4 Jul 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Pharmacy Services: Pharmacy Services (4 Jul 2012)

Róisín Shortall: Shortages of essential medicines are currently a cause of concern not just in Ireland but throughout Europe and the rest of the world. It is a global problem affecting health systems in all countries and impacting on patients world-wide. Medicines shortages can be the result of one, several or any combination of factors throughout the pharmaceutical supply chain such as manufacturing...

Written Answers — Medical Cards: Medical Cards (4 Jul 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Water Fluoridation: Water Fluoridation (4 Jul 2012)

Róisín Shortall: The Forum on Fluoridation Report (2002) found there was no evidence of any negative health effects from the fluoridation of public water supplies. In 2011 the EU Scientific Committee on Health and Environmental Risks (SCHER), published its 'Opinion on critical review of any new evidence on the hazard profile, health effects, and human exposure to fluoride and the fluoridating agents of...

Written Answers — Medical Cards: Medical Cards (4 Jul 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Water Fluoridation: Water Fluoridation (3 Jul 2012)

Róisín Shortall: The Irish Expert Body on Fluorides and Health and its sub-committees have broad representation from areas such as dentistry, biochemistry, environmental health and public health medicine. The Expert Body also has a strong consumer input in terms of members of the public and representatives of consumer interests. The sub-committees of the Expert Body may also co-opt members as the need...

Written Answers — Medicinal Products: Medicinal Products (3 Jul 2012)

Róisín Shortall: Eltroxin, which contains the active substance levothyroxine, is a long-established medicine that is used to control hypothyroidism, congenital hypothyroidism and juvenile myxoedema. It is marketed in tablets containing 25, 50 and 100 micrograms and is the subject of a marketing authorisation in Ireland. The product is manufactured in the United Kingdom. A shortage of Eltroxin emerged in...

Written Answers — Medical Cards: Medical Cards (3 Jul 2012)

Róisín Shortall: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.